| Business Summary | | LifePoint,
Inc.
is
a
medical
technology
company
that
has
designed,
is
manufacturing
and
will
shortly
be
marketing
the
IMPACTTM
Test
System,
a
rapid
diagnostic
testing,
screening,
and
therapeutic
drug
monitoring
device
for
use
in
the
workplace,
home
health
care,
ambulances,
pharmacies
and
law
enforcement.
LifePoint
is
focused
on
the
commercialization
of
the
flow
immunosensor
technology
licensed
from
the
United
States
Navy.
The
first
product
being
commercialized
is
for
the
simultaneous
detection
of
drugs
of
abuse
and
alcohol,
the
market
for
which
is
estimated
to
be
over
$1.6
billion
by
2002. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | LifePoint,
Inc.
is
a
medical
technology
company
that
has
designed,
is
manufacturing
and
will
be
marketing
the
Impact
Test
System,
a
rapid
diagnostic
testing,
screening,
and
therapeutic
drug
monitoring
device.
For
the
three
months
ended
6/30/01,
the
company
reports
no
revenues.
Net
loss
increased
73%
to
$2.5
million.
Results
reflect
the
absence
of
any
revenue-generating
activities,
and
expenses
related
to
the
hiring
of
additional
R&D
personnel. | More
from
Market Guide: Significant
Developments |
| | | | FY2001
Compensation | | Pay | Exer | |
| Linda Masterson, 50 Chairman,
Pres, CEO | $185K | $248K | Thomas Foley, 61 Sr.
VP, R&D | 142K | 272K | Donald Fletcher, 49 VP-Operations | -- | -- | Lawrence Reynolds, 52 VP
of Marketing | 129K | -- | James Canfield, 42 VP
North American Sales | -- | -- | Dollar
amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|